leukemia

DocWire News EditorsOncology | April 13, 2023
The Journey of Roe Roe: A Brave Girl Battling Leukemia ...
Read More
DocWire News EditorsOncology | December 27, 2021
Background aims: Efforts to safely and effectively treat acute myeloid leukemia (AML) by targeting a single ...
DocWire News EditorsASH Annual Meeting and Exposition 2021 | August 25, 2023
TP53 is the most commonly mutated gene in human cancer. Presence of “multi-hit” TP53 mutations is associated with ...
DocWire News EditorsASH Annual Meeting and Exposition 2021 | August 25, 2023
As a plenary abstract at the 2021 ASH Annual Meeting, Alba Rodriguez-Meira, PhD-c, of MRC Weatherall Institute of ...
Rebecca AraujoOncology | December 10, 2021
Each week on DocWire News, editors bring you the latest in oncology news and cancer research. In case you missed it, ...
DocWire News EditorsOncology | March 31, 2023
A review and meta-analysis published in Clinical Lymphoma, Myeloma & Leukemia, investigated the association between ...
Rebecca AraujoOncology | September 3, 2021
Did you know September is Blood Cancer Awareness Month? This month, take the time to learn more about this disease, ...
Rebecca AraujoOncology | August 21, 2023
Each week on DocWire, editors bring you the latest news and research in hematology and oncology. Here are this week's ...
DocWire News EditorsOncology | June 7, 2021
A retrospective study published in Cancer Medicine provided real-world data on patients with chronic myelomonocytic ...
Rob DillardHematology | August 31, 2023
When physicians suspect a diagnosis of certain conditions, a referral to a hematologist is warranted.
Rebecca AraujoOncology | March 31, 2023
A research team in Norway found that previous hematological malignancies were associated with a subsequent diagnosis of ...
Rob DillardOncology | December 7, 2020
A study assessed the mechanisms of CD20 monoclonal antibodies (mAbs) with B-cell receptor (BCR)-associated kinase (BAKi) ...
Rebecca AraujoOncology | October 26, 2020
Researchers from the University of Alberta have identified a new mechanism of cell signal inhibition that could prove ...
Rob DillardOncology | September 9, 2020
A study which appeared in the journal Oncotarget sheds light on why people with Down syndrome are at higher risk of ...
DocWire News EditorsOncology | August 6, 2020
A bispecific chimeric antigen receptor (CAR) T-cell therapy targeting CD19 and CD22 induced remission in adult patients ...
Kerri FitzgeraldOncology | April 27, 2020
The U.S. Food and Drug Administration (FDA) approved Imbruvica® (ibrutinib) in combination with Rituxan® (rituximab) ...
Kaitlyn D’OnofrioCOVID-19 | September 21, 2023
An article published in Leukemia Research outlined factors to consider when treating patients with acute leukemia during ...
Kerri FitzgeraldOncology | June 27, 2023
An anti-CD19 chimeric antigen receptor (CAR) T-cell-transduced natural killer (NK) therapy induced responses in patients ...
Kerri FitzgeraldOncology | January 14, 2020
A study published in JNCI Cancer Spectrum observed an increased risk of prostate cancer, thyroid cancer, and leukemia in ...
DocWire News EditorsHeart Failure | May 2, 2023
Patients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) who are treated with anthracyclines ...
Advertisement
Advertisement
Latest News

February 23, 2024